Duearity Investor Relations Material

Duearity AB is a Swedish medical technology company specializing in innovative solutions for tinnitus treatment. The company's primary product, Tinearity G1, is a medical device designed to alleviate tinnitus symptoms through a non-invasive method that uses white noise delivered via the skull bone, bypassing the ear canal. This approach is based on Tinnitus Retraining Therapy, which has been used clinically for several decades. The company is headquartered in Malmö, Sweden, and its shares are listed on the Nasdaq Stockholm.